GABA_A Receptors in Central Nervous System Disease: Anxiety, Epilepsy, and Insomnia

REFERENCES

• Olsen R W, DeLorey T M, Gordey M, Kang M H. GABA receptor function and epilepsy. Adv Neurol 1999; 79: 499–510
   PubMedGoogle Scholar
• Möhler H. Pathophysiological aspects of diversity in neuronal inhibition: A new benzodiazepine pharmacology. Dialog Clin Neurosci 2002; 4: 261–269
   PubMedGoogle Scholar
• Möhler H, Fritschy J M, Vogt K, Crestani F, Rudolph U. Pathophysiology and pharmacology of GABAA receptors. Handb Exp Pharmacol 2005; 169: 225–247
   Google Scholar
• Feusner J, Richie T, Lawford B, Young R M, Kann B, Noble E P. GABAA receptor beta3 subunit gene and psychiatric morbidity in a post-traumatic stress disorder population. Psychiatry Res 2001; 104: 109–117
   PubMed Web of Science ®Google Scholar
• Taylor M, Bhagwagar Z, Cowen P J, Sharp T. GABA and mood disorders. Psych Med 2003; 33: 3873–3893
   Google Scholar
• Loh E W, Ball D. Role of the GABA-Aγ2 receptor subunit genes cluster in drug responses and the development of alcohol dependence. Neurochem Int 2000; 37: 413–423
   PubMedGoogle Scholar
• Parsian A, Zhang Z H. Human chromosomes 11p15 and 4p12 and alcohol dependence. Possible association with the GABBR1 gene. Am J Med Genet 1999; 88: 533–538
   PubMedGoogle Scholar
• Bianchi M T, Song L, Zhang H, Macdonald R L. Two different mechanisms of disinhibition produced by GABAA receptor mutations linked to epilepsy in humans. J Neurosci 2002; 22: 5321–5327
   PubMed Web of Science ®Google Scholar
• Weiller E, Bisserbe J C, Maier W, Lecrubier Y. Prevalence and recognition of anxiety syndromes in five European primary care settings. A report from the WHO study on Psychological Problems in General Health Care. Br J Psychiatry 1998; 173: 18–23
   Web of Science ®Google Scholar
• Kalueff A, Nutt D J. Role of GABA in memory and anxiety. Depress Anxiety 1997; 4: 100–110
   Google Scholar
• Malizia A L, Cunningham V J, Bell C J, Liddle P F, Jones T, Nutt D J. Decreased brain GABAA-benzodiazepine receptor binding in panic disorders: Preliminary results from a quantitative PET study. Arch Gen Psychiatry 1998; 55: 715–720
   PubMed Web of Science ®Google Scholar
• Malizia A L. What do brain imaging studies tell us about anxiety disorders?. J Psychopharmacol 1999; 13: 372–378
   PubMed Web of Science ®Google Scholar
• Tiihonen J, Kuikka J, Rasanen P, Lepola U, Koponen H, Liuska A, Lehmusvaara A, Vainio P, Kononen M, Bergstrom K, Yu M, Kinnunen I, Akerman K, Karhu J. Cerebral benzodiazepine receptor binding and distribution in generalized anxiety disorders: A fractal analysis. Mol Psychiatry 1997; 6: 463–471
   Google Scholar
• Goddard A W, Mason G F, Almai A, Rothman D L, Behar K L, Petroff O A, Chamey D S, Krystal J H. Reductions in occipital cortex GABA levels in panic disorder detected 1H MRS. Arch Gen Psychiatry 2001; 58: 556–561
   PubMed Web of Science ®Google Scholar
• Nutt D J, Malizia A L. New insights into the role of the GABAA receptor in psychiatric disorders. B. J Psychiatry 2001; 179: 390–396
   PubMed Web of Science ®Google Scholar
• Crestani F, Lorez M, Baer K, Essrich C, Benke D, Laurent J P, Belzung C, Fritschy J M, Luscher B, Möhler H. Decreased GABAA-receptor clustering results in enhanced anxiety and a bias for threat cues. Nat Neurosci 1999; 2: 833–839
   PubMed Web of Science ®Google Scholar
• Eysenck M W. The nature of anxiety. Handbook of Individual Differences: Biological Perspectives, A Gale, M W Eysenck. Wiley, New York 1992; 157–178
   Google Scholar
• Baulac S, Huberfeld G, Gourfinkel-An I, Mitropoulou G, Beranger A, Prud'homme J F, Baulac M, Brice A, Bruzzone R, LeGuern E. First genetic evidence of GABAA receptor dysfunction in epilepsy: A mutation in the γ2-subunit gene. Nat Genet 2001; 28: 46–48
   PubMed Web of Science ®Google Scholar
• Wallace R H, Marini C, Petrou S, Harkin L A, Bowser D N, Panchal R G, Williams D A, Sutherland G R, Mulley J C, Scheffer I E, Berkovic S F. Mutant GABAA receptor γ2-subunit in childhood absence epilepsy and febrile seizures. Nat Genet 2001; 28: 49–52
   PubMed Web of Science ®Google Scholar
• Kananura C, Haug K, Sander T, Runge U, Gu W, Hallmann K, Rebstock J, Heils A, Steinlein O K. A splice-site mutation in GABRG2 associated with childhood absence epilepsy and febrile convulsions. Arch Neurol 2002; 59: 1137–1141
   PubMedGoogle Scholar
• Cossette P, Liu L, Brisebois K, Dong H, Lortie A, Vanasse M, Saint-Hilaire J M, Carmant L, Verner A, Lu W Y, Wang Y T, Rouleau G A. Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy. Nat Genet 2002; 31: 184–189
   PubMed Web of Science ®Google Scholar
• Coulter D A. Epilepsy-associated plasticity in γ-aminobutyric acid receptor expression, function, and inhibitory synaptic properties. Int Rev Neurobiol 2001; 45: 237–252
   PubMedGoogle Scholar
• Treimann D M. GABAergic mechanisms in epilepsy. Epilepsia 2001; 42: 8–12
   PubMedGoogle Scholar
• Snead O C, Depaulis A, Vergues M, Marescaux C. Absence epilepsy: Advances in experimental animal models. Adv Neurol 1999; 79: 253–278
   PubMedGoogle Scholar
• Loup F, Wieser H G, Yonekawa Y, Aguzzi A, Fritschy J M. Selective alterations in GABAA receptor subtypes in human temporal lobe epilepsy. J Neurosci 2000; 20: 5401–5419
   PubMedGoogle Scholar
• Riban V, Bouilleret V, Pham-Lé B T, Fritschy J M, Marescaux C, Depaulis A. Evolution of hippocampal epileptic activity during the development of hippocampal sclerosis in a mouse model of temporal lobe epilepsy. Neurosci 2002; 112: 101–111
   PubMed Web of Science ®Google Scholar
• Bouilleret V, Loup F, Kiener T, Marescaux C, Fritschy J M. Early loss of interneurons and delayed subunit-specific changes in GABAA-receptor expression in a mouse model of mesial temporal lobe epilepsy. Hippocampus 2000; 10: 305–324
   PubMedGoogle Scholar
• Arabadzisz D, Antal K, Parpan F, Enri Z, Fritschy J M. Epileptogenesis and chronic seizures in a mouse model of temporal lobe epilepsy are associated with distinct EEG patterns and selective neurochemical changes in the contralateral hippocampus. Exp Neurol 2005; 194: 76–90
   PubMedGoogle Scholar
• Cohen I, Navarro V, Clemenceau S, Baulac M, Miles R. On the origin of interictal activity in human temporal lobe epilepsy in vitro. Science 2002; 298: 1418–1421
   PubMed Web of Science ®Google Scholar
• Gulledge A T, Stuart G J. Excitatory actions of GABA in the cortex. Neuron 2003; 37: 299–309
   PubMedGoogle Scholar
• Stein V, Nicoll R A. GABA generates excitement. Neuron 2003; 37: 375–378
   PubMed Web of Science ®Google Scholar
• Meldrum B S, Whiting P. Anticonvulsants acting on the GABA system. Pharmacology of GABA and Glycine Neurotransmission, H Möhler. Springer Publishers, New York 2001; 173–194
   Google Scholar
• Sohal V S, Keist R, Rudolph U, Huguenard J R. Dynamic GABAA receptor subtype specific modulation of the synchrony and duration of thalamic oscillations. J Neurosci 2003; 23: 3649–3657
   PubMedGoogle Scholar
• Woo T U, Whitehead R E, Melchitzky D S, Jewis D A. A subclass of prefrontal GABA axon terminals are selectively altered in schizophrenia. Proc Natl Acad Sci USA 1998; 95: 5341–5346
   PubMed Web of Science ®Google Scholar
• Volk D W, Fritschy J M, Pierri J N, Auh S, Sampson A R, Lewis D A. Reciprocal alterations in pre-and postsynaptic inhibitory markers at chandelier cell inputs to pyramidal neurons in schizophrenia. Cereb Cortex 2002; 12: 1063–1070
   PubMed Web of Science ®Google Scholar
• Huntsman M M, Tran B V, Potkin S G, Bunney Wejr, Jones E G. Altered ratios of alternatively spliced γ2 subunit of mRNAs of GABAA receptors in prefrontal cortex of schizophrenics. Proc Nat Acad Sci USA 1998; 95: 15066–15071
   PubMed Web of Science ®Google Scholar
• Sarter M, Bruno J P, Berntson G G. Psychotogenic properties of benzodiazepine receptor inverse agonists. Psychopharmacol 2001; 156: 1–13
   Google Scholar
• Mrzljak L, Bergson C, Pappy M, Huff R, Levenson R, Goldman-Rakic P S. Localization of D4 receptors in GABAergic neurons in primate brain. Nature 1996; 381: 245–248
   PubMed Web of Science ®Google Scholar
• Carlsson A, Waters N, Holm-Waters S, Tedroff J, Nilsson M, Carlsson M L. Interactions between monoamines, glutamate, and GABA in schizophrenia: New evidence. Annu Rev Pharmacol Toxicol 2001; 41: 237–260
   PubMed Web of Science ®Google Scholar
• Lewis D A, Hashimoto T, Volk D W. Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci 2005; 6: 312–324
   PubMed Web of Science ®Google Scholar
• Fritschy J M, Möhler H. GABAA receptor heterogeneity in the adult rat brain: Differential regional and cellular distribution of seven major subunits. J Comp Neurol 1995; 359: 154–194
   PubMed Web of Science ®Google Scholar
• Pirker S, Schwarzer C, Wieselthaler A, Sieghart W, Sperk G. GABAA receptors: Immunocytochemical distribution of 13 subunits in the adult rat brain. Neurosci 2000; 101: 815–850
   PubMed Web of Science ®Google Scholar
• Yee B K, Keist R, von Boehmer L, Studer R, Benke D, Hagenbuch N, Dong Y, Malenka R C, Fritschy J M, Bluethmann H, Feldon J, Mohler H, Rudolph U. A schizophrenia-related sensorimotor deficit links α3-containing GABAA receptors to a dopamine hyperfunction. Proc Natl Acad Sci USA 2005; 102: 17154–17159
   PubMed Web of Science ®Google Scholar
• Dellini-Stula A, Berdah-Tordjman D. Antipsychotic effects of bretazenil, a partial benzodiazepine agonist in acute schizophrenia—A study group report. J Psychiatry Res 1996; 30: 239–250
   PubMedGoogle Scholar
• Crestani F, Keist R, Fritschy J M, Benke D, Vogt K, Prut L, Bluethmann H, Möhler H, Rudolph U. Trace fear conditioning involves hippocampal α5 GABAA receptors. Proc Natl Acad Sci USA 2002; 99: 8980–8985
   PubMed Web of Science ®Google Scholar
• Hauser J, Rudolph U, Keist R, Möhler H, Feldon J, Yee B. Hippocampal α5 subunit containing GABAA receptors modulate expression of prepulse inhibition. Mol Psychiatry 2005; 10: 201–207
   PubMedGoogle Scholar
• Spencer K M, Nestor P G, Perlmutter R, Niznikiewicz M A, Klump M C, Frumin M, Shenton M E, Mc Carley R W. Neural synchrony indexes disordered perception and cognition in schizophrenia. Proc Natl Acad Sci USA 2004; 101: 17288–17293
   PubMed Web of Science ®Google Scholar
• Buhr A, Bianchi V, Boulenger J P, Gallati S, Hinkle D J, McDonald R L, Sigel E. Functional characterization of the new human GABA receptor missense mutation β3(R192H). Hum Genet 2002; 111: 154–160
   PubMed Web of Science ®Google Scholar
• Tobler I, Kopp C, Deboer T, Rudolph U. Diazepam-induced changes in sleep: Role of the α1GABAA receptor subtype. Proc Natl Acad Sci USA 2001; 98: 6464–6469
   PubMed Web of Science ®Google Scholar
• Kopp C, Rudolph U, Löw K, Tobler I. Modulation of rhythmic brain activity by diazepam: GABA(A) receptor subtype and state specificity. Proc Natl Acad Sci USA 2004; 101: 3674–3679
   PubMed Web of Science ®Google Scholar
• Brown N, Kerby J, Bonnert T P, Whiting P J, Wafford K A. Pharmacological characterization of a novel cell line expressing human α4β3δ GABAA receptors. Brit J Pharmacol 2002; 136: 965–974
   PubMed Web of Science ®Google Scholar
• Stornstovu S, Ebert B. Gaboxadol: In vitro interaction studies with benzodiazepines and ethanol suggest functional selectivity. Eur J Pharmacol 2003; 467: 49–56
   PubMedGoogle Scholar
• Lancel M, Steiger A. Sleep and its modulation by drugs that affect GABAA receptor function. Ang Chem Int Ed 1999; 111: 2852–2864
   Google Scholar